Home > Insider Trading > Filing (0001596783-24-000045)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596783	Catalent Inc.	CTLT	Pharmaceutical Preparations (2834)	208737688

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1612357	Aristippos Gennadios	C/O Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873	Group Pres. Pharma & Consumer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-07-26	18,746	$0.00	115,242	No	4	A	Direct
Common Stock	Disposition	2024-07-29	349	$58.70	114,893	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Restricted stock units (RSUs) received by the reporting person pursuant to the Issuers annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuers common stock as of the date of vesting, which will occur in three equal annual installments beginning on July 26, 2025.
Includes RSU.
Shares sold by the reporting person through an automatic sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuers omnibus incentive plan. No shares were withheld by or surrendered to the Issuer.
Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $58.67 to $58.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.